Association between Serum Total Osteocalcin Level and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

 

 Buy Article Permissions and Reprints

Abstract

Studies on the association between serum total osteocalcin level and type 2 diabetes mellitus (T2DM) had reported controversial results. The aim of this study was to comprehensively assess this association through a meta-analysis. Eligible articles were identified in electronic databases from their inception through May 1, 2015. To assess the relationship between serum total osteocalcin and T2DM, a meta-analysis was performed to determine whether total osteocalcin differed obviously between individuals with and without T2DM, and whether serum total osteocalcin level was associated with the risk of T2DM. The standardized mean difference (SMD) and their 95% confidence intervals (95% CIs) for total osteocalcin between individuals with and without T2DM, and pooled odds ratios (ORs) and their 95% CI for the T2DM risk were calculated by meta-analysis. Twenty-four papers fulfilled the inclusion criteria. From the pooled data, the total osteocalcin level was significantly lower among T2DM patients than controls (SMD: − 2.87; 95% CI−3.76 to − 1.98; p<0.00001), and high total osteocalcin level was significantly and independently associated with decreased risk of T2DM (OR=0.70, 95% CI 0.56–0.88; p=0.002). There was no evidence for publication bias. Serum total osteocalcin level is significantly lower in T2DM patients than controls, and total osteocalcin is inversely associated with the development of T2DM.

• References

• 1 Unger RH. Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab 2003; 14: 398-403
  CrossrefPubMedGoogle Scholar
• 2 Schwarz PE, Albright AL. Prevention of type 2 diabetes: the strategic approach for implementation. Horm Metab Res 2011; 43: 907-910
  Article in Thieme ConnectPubMedGoogle Scholar
• 3 Dobnig H, Piswanger-Solkner JC, Roth M, Obermayer-Pietsch B, Tiran A, Strele A, Maier E, Maritschnegg P, Sieberer C, Fahrleitner-Pammer A. Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk. J Clin Endocrinol Metab 2006; 91: 3355-3363
  CrossrefPubMedGoogle Scholar
• 4 Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 2008; 105: 5266-5270
  CrossrefPubMedGoogle Scholar
• 5 Ngarmukos C, Chailurkit LO, Chanprasertyothin S, Hengprasith B, Sritara P, Ongphiphadhanakul B. A reduced serum level of total osteocalcin in men predicts the development of diabetes in a long-term follow-up cohort. Clin Endocrinol 2012; 77: 42-46
  CrossrefPubMedGoogle Scholar
• 6 Zhou Y, Li Y, Zhang D, Wang J, Yang H. Prevalence and predictors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetes. Diabetes Res Clin Pract 2010; 90: 261-269
  CrossrefPubMedGoogle Scholar
• 7 Ma H, Lin H, Hu Y, Li X, He W, Jin X, Gao J, Zhao N, Gao X. Serum levels of osteocalcin in relation to glucose metabolism and carotid atherosclerosis in Chinese middle-aged and elderly male adults: the Shanghai Changfeng Study. Eur J Int Med 2014; 25: 259-264
  CrossrefPubMedGoogle Scholar
• 8 Zhou M, Ma X, Li H, Pan X, Tang J, Gao Y, Hou X, Lu H, Bao Y, Jia W. Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur J Endocrinol 2009; 161: 723-729
  CrossrefPubMedGoogle Scholar
• 9 Hwang YC, Jee JH, Jeong IK, Ahn KJ, Chung HY, Lee MK. Circulating osteocalcin level is not associated with incident type 2 diabetes in middle-aged male subjects: mean 8.4-year retrospective follow-up study. Diabetes Care 2012; 35: 1919-1924
  CrossrefPubMedGoogle Scholar
• 10 Liatis S, Sfikakis PP, Tsiakou A, Stathi C, Terpos E, Katsilambros N, Makrilakis K. Baseline osteocalcin levels and incident diabetes in a 3-year prospective study of high-risk individuals. Diabetes Metab 2014; 40: 198-203
  CrossrefPubMedGoogle Scholar
• 11 Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012
  CrossrefPubMedGoogle Scholar
• 12 Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M. The Newcastle Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses. Ottawa Health Research Institute Web site 2012
  PubMedGoogle Scholar
• 13 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Brit Med J 2003; 327: 557-560
  CrossrefPubMedGoogle Scholar
• 14 DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
  CrossrefPubMedGoogle Scholar
• 15 Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748
  PubMedGoogle Scholar
• 16 Akesson K, Vergnaud P, Delmas PD, Obrant KJ. Serum osteocalcin increases during fracture healing in elderly women with hip fracture. Bone 1995; 16: 427-430
  PubMedGoogle Scholar
• 17 Alselami NM, Noureldeen AF, Al-Ghamdi MA, Khan JA, Moselhy SS. Bone turnover biomarkers in obese postmenopausal Saudi women with type-II diabetes mellitus. African Health Sci 2015; 15: 90-96
  PubMedGoogle Scholar
• 18 Cutrim DM, Pereira FA, de Paula FJ, Foss MC. Lack of relationship between glycemic control and bone mineral density in type 2 diabetes mellitus. Brazil J Med Biol Res 2007; 40: 221-227
  CrossrefPubMedGoogle Scholar
• 19 Gregorio F, Cristallini S, Santeusanio F, Filipponi P, Fumelli P. Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes?. Diabetes Res Clin Pract 1994; 23: 43-54
  CrossrefPubMedGoogle Scholar
• 20 Sarkar PD, Choudhury AB. Relationships between serum osteocalcin levels versus blood glucose, insulin resistance and markers of systemic inflammation in central Indian type 2 diabetic patients. Eur Rev Med Pharmacol Sci 2013; 17: 1631-1635
  PubMedGoogle Scholar
• 21 Yamamoto M, Yamaguchi T, Nawata K, Yamauchi M, Sugimoto T. Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 2012; 97: 1277-1284
  CrossrefPubMedGoogle Scholar
• 22 Manavalan JS, Cremers S, Dempster DW, Zhou H, Dworakowski E, Kode A, Kousteni S, Rubin MR. Circulating osteogenic precursor cells in type 2 diabetes mellitus. J Clin Endocrinol Metab 2012; 97: 3240-3250
  CrossrefPubMedGoogle Scholar
• 23 Shu A, Yin MT, Stein E, Cremers S, Dworakowski E, Ives R, Rubin MR. Bone structure and turnover in type 2 diabetes mellitus. Osteoporosis Inter 2012; 23: 635-641
  PubMedGoogle Scholar
• 24 Zhukouskaya VV, Eller-Vainicher C, Gaudio A, Cairoli E, Ulivieri FM, Palmieri S, Morelli V, Orsi E, Masserini B, Barbieri AM, Polledri E, Fustinoni S, Spada A, Fiore CE, Chiodini I. In postmenopausal female subjects with type 2 diabetes mellitus, vertebral fractures are independently associated with cortisol secretion and sensitivity. J Clin Endocrinol Metab 2015; 100: 1417-1425
  CrossrefPubMedGoogle Scholar
• 25 Yeap BB, Alfonso H, Chubb SA, Gauci R, Byrnes E, Beilby JP, Ebeling PR, Handelsman DJ, Allan CA, Grossmann M, Norman PE, Flicker L. Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men. J Clin Endocrinol Metab 2015; 100: 63-71
  CrossrefPubMedGoogle Scholar
• 26 Choudhury AB, Sarkar PD, Sakalley DK, Petkar SB. Role of adiponectin in mediating the association of osteocalcin with insulin resistance and type 2 diabetes: a cross sectional study in pre- and post-menopausal women. Archiv Physiol Biochem 2014; 120: 73-79
  PubMedGoogle Scholar
• 27 Im JA, Yu BP, Jeon JY, Kim SH. Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clin Chim Acta 2008; 396: 66-69
  CrossrefPubMedGoogle Scholar
• 28 Akin O, Gol K, Akturk M, Erkaya S. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements. Gynecol Endocrinol 2003; 17: 19-29
  CrossrefPubMedGoogle Scholar
• 29 Gennari L, Merlotti D, Valenti R, Ceccarelli E, Ruvio M, Pietrini MG, Capodarca C, Franci MB, Campagna MS, Calabro A, Cataldo D, Stolakis K, Dotta F, Nuti R. Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J Clin Endocrinol Metab 2012; 97: 1737-1744
  CrossrefPubMedGoogle Scholar
• 30 Achemlal L, Tellal S, Rkiouak F, Nouijai A, Bezza A, Derouiche el M, Ghafir D, El Maghraoui A. Bone metabolism in male patients with type 2 diabetes. Clin Rheumatol 2005; 24: 493-496
  CrossrefPubMedGoogle Scholar
• 31 Oz SG, Guven GS, Kilicarslan A, Calik N, Beyazit Y, Sozen T. Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus. J Natl Med Assoc 2006; 98: 1598-1604
  PubMedGoogle Scholar
• 32 Lerchbaum E, Schwetz V, Nauck M, Volzke H, Wallaschofski H, Hannemann A. Lower bone turnover markers in metabolic syndrome and diabetes: The population-based Study of Health in Pomerania. Nutr Metab Cardiovasc Dis 2015; 25: 458-463
  CrossrefPubMedGoogle Scholar
• 33 Hwang YC, Jeong IK, Ahn KJ, Chung HY. Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level. Osteoporosis Inter 2012; 23: 1337-1342
  PubMedGoogle Scholar
• 34 Kunutsor SK, Apekey TA, Laukkanen JA. Association of serum total osteocalcin with type 2 diabetes and intermediate metabolic phenotypes: systematic review and meta-analysis of observational evidence. Eur J Epidemiol 2015; Jun 18 [Epub ahead of print]
  PubMedGoogle Scholar
• 35 Starup-Linde J, Eriksen SA, Lykkeboe S, Handberg A, Vestergaard P. Biochemical markers of bone turnover in diabetes patients–a meta-analysis, and a methodological study on the effects of glucose on bone markers. Osteoporosis Inter 2014; 25: 1697-1708
  PubMedGoogle Scholar
• 36 Hill HS, Grams J, Walton RG, Liu J, Moellering DR, Garvey WT. Carboxylated and uncarboxylated forms of osteocalcin directly modulate the glucose transport system and inflammation in adipocytes. Horm Metab Res 2014; 46: 341-347
  Article in Thieme ConnectPubMedGoogle Scholar
• 37 Eastell R, Ebeling PR. Bone turnover markers: a key tool for understanding osteoporosis. Osteoporosis Inter 2009; 20: 237-238
  PubMedGoogle Scholar
• 38 Hauschka PV, Lian JB, Cole DE, Gundberg CM. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989; 69: 990-1047
  PubMedGoogle Scholar
• 39 Das SK, Elbein SC. The search for type 2 diabetes susceptibility loci: the chromosome 1q story. Curr Diabetes Rep 2007; 7: 154-164
  CrossrefPubMedGoogle Scholar
• 40 Cifuentes M, Johnson MA, Lewis RD, Heymsfield SB, Chowdhury HA, Modlesky CM, Shapses SA. Bone turnover and body weight relationships differ in normal-weight compared with heavier postmenopausal women. Osteoporosis Inter 2003; 14: 116-122
  PubMedGoogle Scholar
• 41 Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G. Endocr regulation of energy metabolism by the skeleton. Cell 2007; 130: 456-469
  CrossrefPubMedGoogle Scholar
• 42 Shea MK, Gundberg CM, Meigs JB, Dallal GE, Saltzman E, Yoshida M, Jacques PF, Booth SL. Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr 2009; 90: 1230-1235
  CrossrefPubMedGoogle Scholar
• 43 Wallace C, Reiber GE, LeMaster J, Smith DG, Sullivan K, Hayes S, Vath C. Incidence of falls, risk factors for falls, and fall-related fractures in individuals with diabetes and a prior foot ulcer. Diabetes Care 2002; 25: 1983-1986
  CrossrefPubMedGoogle Scholar
• 44 Keegan TH, Kelsey JL, Sidney S, Quesenberry Jr CP. Foot problems as risk factors of fractures. Am J Epidemiol 2002; 155: 926-931
  CrossrefPubMedGoogle Scholar
• 45 Gregg EW, Yaffe K, Cauley JA, Rolka DB, Blackwell TL, Narayan KM, Cummings SR. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Inter Med 2000; 160: 174-180
  CrossrefPubMedGoogle Scholar
• 46 Szulc P, Delmas PD. Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis. Osteoporosis Inter 2008; 19: 1683-1704
  PubMedGoogle Scholar
• 47 Khalil N, Sutton-Tyrrell K, Strotmeyer ES, Greendale GA, Vuga M, Selzer F, Crandall CJ, Cauley JA. Menopausal bone changes and incident fractures in diabetic women: a cohort study. Osteoporosis Inter 2011; 22: 1367-1376
  PubMedGoogle Scholar
• 48 Bhattoa HP, Onyeka U, Kalina E, Balogh A, Paragh G, Antal-Szalmas P, Kaplar M. Bone metabolism and the 10-year probability of hip fracture and a major osteoporotic fracture using the country-specific FRAX algorithm in men over 50 years of age with type 2 diabetes mellitus: a case-control study. Clin Rheumatol 2013; 32: 1161-1167
  CrossrefPubMedGoogle Scholar
• 49 Gundberg CM, Looker AC, Nieman SD, Calvo MS. Patterns of osteocalcin and bone specific alkaline phosphatase by age, gender, and race or ethnicity. Bone 2002; 31: 703-708
  CrossrefPubMedGoogle Scholar

• Supplementary Material